Results

1–3 of 3 results for kinase inhibitor

From Bench to Bedside: Investigating the Use of Netarsudil as a Novel Therapeutic Approach for PVR
Leo A. Kim, MD, PhD
Updates from the Field
2025
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)
David M. Brown, MD
Annual Meeting Talks
2020